CONNEQT Health Limited (ASX:CQT)

Market Cap	27.56M -3.2%
Revenue (ttm)	6.05M -52.8%
Net Income	-18.19M
EPS	-0.05
Shares Out	612.38M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	440,679
Average Volume	277,612
Open	0.0440
Previous Close	0.0450
Day's Range	0.0440 - 0.0460
52-Week Range	0.0260 - 0.1550
Beta	0.76
RSI	44.16
Earnings Date	Feb 27, 2026

About CONNEQT Health

CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disord...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CQT

Financial Performance

In fiscal year 2025, CONNEQT Health's revenue was 6.05 million, a decrease of -52.76% compared to the previous year's 12.81 million. Losses were -18.19 million, 168.9% more than in 2024.